Oncogenic mechanisms in renal insufficiency

Area of Science:

• Oncology
• Nephrology
• Cancer Research
• Renal Medicine

Background:

• Rising prevalence of cancer and end-stage renal disease (ESRD).
• Increased survival rates for cancer and ESRD due to medical advances.
• Chemotherapeutics are often renally excreted, complicating cancer treatment in renal insufficiency.
• Renal insufficiency creates a pro-neoplastic state, increasing cancer risk.

Purpose of the Study:

• To review current understanding of the relationship between cancer and renal insufficiency.
• To explore how renal disease influences cancer development and treatment.
• To examine oncogenic mechanisms associated with renal insufficiency.

Main Methods:

• Literature review of current concepts.
• Synthesis of information on cancer and renal insufficiency.
• Discussion of proposed oncogenic mechanisms.

Main Results:

• Renal insufficiency is linked to an increased risk of various cancers, including genitourinary malignancies.
• Dialysis, while life-prolonging for ESRD patients, may increase cancer risk.
• Proposed mechanisms linking renal insufficiency and cancer include immune dysfunction, chronic inflammation, gut microbiota alterations, and renin-angiotensin system stimulation.

Conclusions:

• The interplay between cancer and renal insufficiency is complex and bidirectional.
• Understanding these interactions is crucial for managing patients with both conditions.
• Further research into the proposed oncogenic mechanisms is warranted.